NASDAQ$MDLN
Medline Inc · Q1 2026 earnings
Q1 2026 earnings ·
Briefing
Medline reported Q1 2026 net sales of $7.35B and net income attributable to Medline Inc. of $129M ($0.16 per share).
Net sales grew 11% to $7.35 billion from $6.64 billion. Operating income was $422 million. Net income attributable to Medline Inc. was $129 million, or $0.16 per diluted share, versus $322 million in the prior-year quarter when results benefited from different tax and ownership structures post-IPO.
- Net sales $7.35B (+11% YoY).
- Operating income $422M.
- Net income to Medline Inc. $129M; EPS $0.16.
- Medical-surgical distribution scale supports margins.
Headline financials
Revenue & EPS history
Medline Inc · Revenue · Quarterly
$7.35B
Forward guidance
Post-IPO company discusses share structure, growth investments, and hospital supply demand.
Tailwinds
- Double-digit sales growth.
- Operating income above $400M quarterly.
Headwinds
- Net income down on tax and NCI allocation.
- Competitive pricing in med-surg distribution.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 2 quarterly earnings reports · overlaid with Q1 2026
-5.5%
Avg return
Earnings day
-10.8%
Avg return
5 days after
-21.6%
Avg return
30 days after
0%
0 / 2 earnings
Positive
-3.6%
Q4 2025
Best reaction
-7.3%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -7.3% | -13.4% | -25.9% | |
| Q4 2025 | -3.6% | -8.3% | -17.3% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro